An analysis of data from a randomized clinical trial for patients with stage 3 colon cancer found that those with PIK3CA mutations who took celecoxib, an anti-inflammatory drug, after surgery lived significantly longer and had longer…
Air pollution significantly worsens cardiovascular risks in cancer survivors, contributing to higher morbidity and mortality, with the most profound impacts on disadvantaged populations. Although modern...
Modern therapies have extended the lives of many cancer patients; however, survivors often live with chronic health conditions, including cardiovascular disease. New research published in the Journal of the American College of Cardiology…
A system failure at Royal Surrey Hospital has seen appointments cancelled as the centre declared a critical incident - which is impacting patients at the Cancer Centre
Organizations like the Pediatric Cancer Research Foundation have made it their mission to help accelerate scientific breakthroughs in hopes of someday reducing the number of children who die from cancer to zero. There are many challenges…
OpenAI and Color Health are partnering to accelerate treatment for cancer patients. Color Health's new copilot app will leverage OpenAI's flagship GPT-4o model capabilities "to identify missing diagnostics and create tailored workup plans,
A study published in JAMA Network Open by an international cohort of researchers provides the latest data on the effectiveness of treating pancreatic cancer patients with chemotherapy (with or without radiation therapy) before surgery to…
Tuesday, AstraZeneca Plc (NASDAQ:AZN) announced topline data from the CAPItello-290 Phase 3 trial for Truqap (capivasertib) in combination with paclitaxel in patients with locally advanced (inoperable) or metastatic triple-negative breast…
Color Health is using OpenAI’s GPT-4o technology to create customised cancer treatment plans for patients, as more companies explore GenAI applications in healthcare
OpenAI and Color Health collaborated to introduce new AI tool to help the cancer patient access expertise and treatment. The AI tool aims to bring specialised cancer knowledge to primary care and help build risk-adjusted screening…
The partial hold affects the enrollment of new U.S. patients in the Phase I trial (NCT05653752), a MedLink-sponsored study designed to assess BNT326/YL202 as a later-line treatment in heavily pre-treated patients with advanced or…
(MedPage Today) -- Two new immunotherapy-chemotherapy options are now approved for patients with primary advanced or recurrent endometrial cancer, the FDA announced.
Cancer diagnoses in adolescents in young adults are rising. These patients are not only navigating the challenges of a life-altering diagnosis, but also other challenges distinct to their life stage.
University of Oxford researchers have leveraged the power of artificial intelligence (AI) to develop personalized cancer treatments which could be more effective at preventing patient relapse.
OpenAI’s GPT-4o artificial intelligence (AI) model is powering a copilot application designed to accelerate cancer patients’ access to treatment by identifying missing diagnostics and creating tailored workup plans. Developed by Color…
Figures come amid record dissatisfaction with GPs and long waits for diagnostic tests, with patients often struggling to be seen. Cancer Research UK described the situation as 'unacceptable'.
Cross-border tumor boards of cancer specialists from different European countries meeting virtually to review the management of individual patients with complex rare gynecological cancers from across Europe resulted in new treatment…